Fingerprint
Dive into the research topics where Kyoung Ah Kim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Add-On Treatment with Gliclazide for Cancer Patients with Type 2 Diabetes Undergoing Cyclic Glucocorticoid-Containing Chemotherapy
Lee, S. E., Park, J. H., Kim, D., Lee, H. A., Kang, Y. S., Yoon, Y. S., Jeong, Y. J., Choi, H. S. & Kim, K. A., May 2025, In: Biomedicines. 13, 5, 1101.Research output: Contribution to journal › Article › peer-review
Open Access -
Discrepancies in Dapagliflozin Response in Terms of Glycemic Control and Body Weight Reduction
BEYOND Investigators, Apr 2025, In: Endocrinology and Metabolism. 40, 2, p. 278-288 11 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Dual add-on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 study
Han, K. A., Hwang, Y. C., Moon, S. J., Cho, H. C., Yoo, H. J., Choi, S. H., Chon, S., Kim, K. A., Kim, T. N., Kang, J. G., Park, C. Y., Won, J. C., Cho, E., Kim, J. & Park, K. S., Sep 2024, In: Diabetes, Obesity and Metabolism. 26, 9, p. 3743-3752 10 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Efficacy and safety of dapagliflozin add-on to evogliptin plus metformin therapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled study
Jeong, I. K., Choi, K. M., Han, K. A., Kim, K. A., Kim, I. J., Han, S. J., Lee, W. Y. & Yoo, S. J., Nov 2024, In: Diabetes, Obesity and Metabolism. 26, 11, p. 5065-5077 13 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE)
Kim, N. H., Lee, J., Chon, S., Yu, J. M., Jeong, I. K., Lim, S., Kim, W. J., Song, K., Cho, H. C., Yu, H. M., Kim, K. A., Kim, S. S., Lee, S. H., Kim, C. H., Kwak, S. H., Lee, Y. H., Chung, C. H., Lee, S., Jin, H. Y. & Lee, J. H. & 26 others, , Oct 2024, In: Endocrinology and Metabolism. 39, 5, p. 722-731 10 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations